Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation

被引:5
|
作者
Miguel Rivera-Caravaca, Jose [1 ]
Marin, Francisco [1 ]
Asuncion Esteve-Pastor, Maria [1 ]
Galvez, Josefa [2 ]
Lip, Gregory Y. H. [3 ,4 ,5 ]
Vicente, Vicente [2 ]
Roldan, Vanessa [2 ]
机构
[1] Univ Murcia, Hosp Clin Univ Virgen de la Arrixaca, Inst Murciano Invest Biosanitaria IMIB Arrixaca, Dept Cardiol,CIBERCV, Murcia, Spain
[2] Univ Murcia, Hosp Gen Univ Morales Meseguer, Inst Murciano Invest Biosanitaria IMIB Arrixaca, Dept Hematol & Clin Oncol, Murcia, Spain
[3] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[4] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
[5] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark
来源
BMJ OPEN | 2019年 / 9卷 / 12期
关键词
CLINICAL CLASSIFICATION SCHEMES; BLEEDING RISK-FACTORS; NATIONAL REGISTRY; PREDICTING STROKE; SCORE; ANTICOAGULATION; STRATIFICATION; HEMORRHAGE; WARFARIN; DEFINITION;
D O I
10.1136/bmjopen-2019-033712
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Atrial fibrillation (AF) is characterised by a high stroke risk. Vitamin K antagonists (VKAs) are the most commonly used oral anticoagulants (OACs) in Spain, but their efficacy and safety depend on the time in therapeutic range of International Normalized Ratio (INR) 2.0-3.0 over 65%-70%. Unfortunately, the difficulties of maintaining an optimal level of anticoagulation and the complications of VKAs (particularly haemorrhagic ones), frequently lead to cessation of this therapy, which has been associated with higher risk of adverse events (AEs), including ischaemic stroke. Our aims are as follows: (1) to evaluate the quality of oral anticoagulation with VKAs, the prevalence of poor quality of anticoagulation, and to identify factors predisposing to poor quality anticoagulation; and (2) to identify patients who will stop OAC and to investigate what factors influence the decision of OAC withdrawal. Methods and analysis Prospective observational cohort study including outpatients newly diagnosed with AF and naive for OACs from July 2016 to June 2018 in an anticoagulation clinic. Patients with prosthetic heart valves, rheumatic mitral valves or valvular AF will be excluded. Follow-up will extend for up to 3 years. During this period, the INR results and changes in the anticoagulant therapy will be recorded, as well as all AEs, or any other information that would be relevant to the proper conduct of research. Ethics and dissemination All patients were informed about the nature and purpose of the study, and the protocol was approved by the Ethics Committee of Hospital General Universitario Morales Meseguer (reference: EST:20/16). This is an observational study focusing on 'real life' practice and therefore all treatments and follow-up will be performed in accordance to the routine clinical practice with no specific interventions or visits. The results of our study will be disseminated by presentations at national and international meetings, and publications in peer-reviewed journals.
引用
收藏
页数:6
相关论文
共 50 条
  • [2] Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation( vol 12, artn e033712 ,year 2022 )
    Rivera-Caravaca, J. M.
    Marin, F.
    Esteve-Pastor, M. A.
    BMJ OPEN, 2022, 12 (12):
  • [3] The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort
    José Miguel Rivera-Caravaca
    Vanessa Roldán
    Lorena Martínez-Montesinos
    Vicente Vicente
    Gregory Y.H. Lip
    Francisco Marín
    Journal of General Internal Medicine, 2023, 38 : 315 - 323
  • [4] The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort
    Miguel Rivera-Caravaca, Jose
    Roldan, Vanessa
    Martinez-Montesinos, Lorena
    Vicente, Vicente
    Lip, Gregory Y. H.
    Marin, Francisco
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 (02) : 315 - 323
  • [5] Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project
    Miguel Rivera-Caravaca, Jose
    Roldan, Vanessa
    Romera, Marta
    Asuncion Esteve-Pastor, Maria
    Valdes, Mariano
    Lip, Gregory Y. H.
    Vicente, Vicente
    Marin, Francisco
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 (06) : 847 - 854
  • [6] Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project
    José Miguel Rivera-Caravaca
    Vanessa Roldán
    Marta Romera
    María Asunción Esteve-Pastor
    Mariano Valdés
    Gregory Y. H. Lip
    Vicente Vicente
    Francisco Marín
    Journal of General Internal Medicine, 2018, 33 : 847 - 854
  • [7] Gastroesophageal reflux disease in patients with atrial fibrillation: a prospective observational study
    Floria, M.
    Barboi, O.
    Grecu, M.
    Rezus, C.
    Cijevschi-Prelipcean, C.
    Balan, Ghe
    Drug, V. L.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2015, 45 : 45 - 45
  • [8] A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: The Loire Valley Atrial Fibrillation Project
    Banerjee, A.
    Halimi, J.
    Vourc'h, P.
    Andres, C. R.
    Taillandier, S.
    Lip, G. Y. H.
    Fauchier, L.
    EUROPEAN HEART JOURNAL, 2013, 34 : 1039 - 1040
  • [9] Multimorbidity, frailty and malnutrition: moving beyond traditional risk factors for risk assessment in atrial fibrillation. The Murcia Atrial Fibrillation Project II
    Rivera-Caravaca, J. M.
    Zazo-Luengo, B.
    Martinez-Montesinos, L.
    Lopez-Galvez, R.
    Garcia-Tomas, L.
    Lip, G. Y. H.
    Marin, F.
    Roldan, V.
    EUROPEAN HEART JOURNAL, 2022, 43 : 635 - 635
  • [10] Atrial fibrillation and antithrombotic treatment in Italian hospitalized patients: A prospective, observational study
    Ageno W.
    Ambrosini F.
    Nardo B.
    Imperiale D.
    Dentali F.
    Mera V.
    Cattaneo R.
    Barlocco E.
    Steidl L.
    Venco A.
    Journal of Thrombosis and Thrombolysis, 2001, 12 (3) : 225 - 230